查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1547080

乳房病变定位市场：2024-2031年全球产业分析、规模、占有率、成长、趋势、预测

Breast Lesion Localization Methods Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 154 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球乳房病变定位市场的详细报告。本报告对驱动因素、趋势、机会和挑战等关键市场动态进行了全面分析，提供了对市场结构的深入见解。

主要见解

  • 乳房病灶定位市场规模（2024年）：25.2亿美元
  • 预估市值（2031年）：68亿美元
  • 全球市场成长率（2024-2031年年复合成长率）：5.7%

乳房病变定位市场：调查范围

乳房病变定位市场包括用于在手术或切片检查之前精确定位和标记乳房内异常组织的各种技术和设备。这些方法对于精确去除癌症或可疑组织、最大限度地减少对周围健康组织的损害以及改善患者的治疗效果非常重要。该市场服务于医院、门诊手术中心和专科诊所等不同领域。乳癌发病率的不断上升、影像技术的进步以及微创手术在各种医疗保健环境中的广泛应用推动了这一成长。

推动市场成长的因素：

有几个关键因素推动全球乳房病变定位市场。随着越来越多的患者需要准确的病变定位，全球乳癌发生率的上升推动市场成长。诊断影像和定位技术的技术进步，例如无线和放射性种子定位方法的开发，提高乳房病变定位的准确性和安全性，进一步刺激市场扩张。此外，早期检测意识的提高和筛检计划可用性的提高推动需求。加强研发活动以及创新设备和技术的引进，为具有各种医疗需求的患者提供更好的解决方案，促进市场成长。

市场限制因素：

儘管成长前景广阔，但乳房病变定位市场受到先进定位技术的高成本以及与某些方法相关的潜在风险的限制，例如线移动和种子错位面临与重大风险相关的挑战。此外，替代诊断影像解决方案的可用性也可能阻碍市场成长，这种解决方案可能因其非侵入性而受到一些医疗保健提供者的青睐。此外，对在资源匮乏的环境中获得先进的本地化诊断方法的担忧对市场扩张构成了挑战。解决这些问题需要持续投资于研究和开发，以提高乳房病变定位方法的安全性、可负担性和可近性。

市场机会：

这个市场的一个重要机会是日益采用无线和放射性种子定位技术，以提高患者的舒适度和治疗效果。数位乳房断层合成和磁振造影（MRI）等先进影像技术的发展是为了满足对更准确、侵入性更小的定位选项日益成长的需求。新兴市场医疗保健基础设施的扩张为市场成长提供了新的管道，使公司能够覆盖更多的患者群体并提供尖端的本地化方法。战略合作伙伴关係、投资医疗保健专业人员培训计划以及采用以患者为中心的方法对于利用新的商机和保持市场领先地位非常重要。

报告中回答的主要问题

  • 推动全球乳房病变定位市场成长的关键因素是什么？
  • 哪些类型和技术的乳房病变定位在各种医疗机构中处于领先地位？
  • 技术进步如何影响乳房病变定位市场的竞争格局？
  • 谁是乳房病变定位市场的主要参与者？ 他们采取哪些策略来保持竞争力？
  • 全球乳房病变定位市场有何新趋势与前景？

目录

第1章 执行摘要

第2章 市场概述

  • 市场范围与定义
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 课题
    • 主要趋势
  • 宏观经济因素
    • 世界 GDP 成长前景
    • 全球医疗保健产业概览
  • 预测因子 - 相关性和影响

第3章 增值见解

  • 产品类型生命週期分析
  • 母市场分析
  • 疾病流行病学
  • 新冠肺炎（COVID-19）影响评估
  • PESTLE分析
  • 波特五力分析
  • 监管与科技环境

第4章 全球乳房病变定位市场展望：实绩（2019-2023年）与预测（2024-2031年）

  • 主要亮点
    • 市场规模及年成长率
    • 绝对数量的机会
  • 市场规模分析与预测（十亿美元）
    • 过去的市场规模分析，2019-2023年
    • 目前市场规模预测（2023-2031年）
  • 全球乳房病变定位市场展望：技术类型
    • 简介/主要发现
    • 2019-2023年历史市场规模（十亿美元）分析，依技术类型
    • 2024-2031年当前市场规模（十亿美元）预测，依技术类型
  • 市场吸引力分析：技术类型
  • 全球乳房病变定位市场展望：最终用户
    • 简介/主要发现
    • 2019-2023年历史市场规模（十亿美元）分析，依最终用户
    • 对2024-2031年当前市场规模（十亿美元）预测，依最终用户
  • 市场吸引力分析：最终用户

第5章 全球乳房病变定位市场展望：地区

  • 主要亮点
  • 2019-2023年历史市场规模（十亿美元）分析，依地区
  • 2024-2031年当前市场规模（十亿美元）预测，依地区
    • 北美
    • 欧洲
    • 东亚
    • 南亚/大洋洲
    • 拉丁美洲
    • 中东和非洲（MEA）
  • 市场吸引力分析：地区

第6章 北美乳房病变定位市场展望：实绩（2019-2023）与预测（2024-2031）

第7章 欧洲乳房病变定位市场展望：实绩（2019-2023年）与预测（2024-2031年）

第8章 东亚乳房病变定位市场展望：实绩（2019-2023）与预测（2024-2031）

第9章 南亚和大洋洲乳房病变定位市场展望：实绩（2019-2023年）和预测（2024-2031年）

第10章 拉丁美洲乳房病变定位市场展望：实绩（2019-2023年）与预测（2024-2031年）

第11章 中东与非洲乳房病变定位市场展望：实绩（2019-2023）与预测（2024-2031）

第12章 竞争态势

  • 2024年市占率分析
  • 市场结构
    • 竞争强度图：依市场划分
    • 竞争仪表板
    • 表观产能
  • 公司简介（详细资料 - 概述、财务状况、策略、近期发展）
    • Merit Medical Systems
    • BD
    • ARGON MEDICAL
    • Hologic, Inc.
    • Endomagnetics Ltd.
    • MatekMedikal
    • Sirius Medical Systems BV
    • Izi Medical Products, LLC
    • Molli Surgical Inc
    • Elucent Medical
    • Intramedical Imaging
    • Isoaid
    • Vigeosrl
    • Medax Medical Devices
    • MDL SRL
    • BPB Medica
    • Sterylab SRL
    • Tsunami Medical Srl
    • Laurane（R）Medical LLC
    • Biomedical Srl

第13章 附录

  • 调查方法
  • 调查的先决条件
  • 首字母缩写词和缩写词
简介目录
Product Code: PMRREP34739

Persistence Market Research has recently published an extensive report on the global Breast Lesion Localization Methods Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • Breast Lesion Localization Methods Market Size (2024E): US$2.52 Bn
  • Projected Market Value (2031F): US$6.8 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 5.7%

Breast Lesion Localization Methods Market - Report Scope:

The Breast Lesion Localization Methods Market encompasses a variety of techniques and devices used to accurately locate and mark the position of abnormal tissue in the breast, typically prior to surgery or biopsy. These methods are critical for ensuring precise removal of cancerous or suspicious tissue, minimizing damage to surrounding healthy tissue, and improving patient outcomes. The market serves diverse segments, including hospitals, ambulatory surgical centers, and specialty clinics. Growth is driven by the increasing prevalence of breast cancer, advancements in imaging technologies, and the expanding application of minimally invasive procedures across various healthcare settings.

Market Growth Drivers:

Several key factors are driving the global Breast Lesion Localization Methods Market. The rising incidence of breast cancer globally boosts the market's growth as more patients require accurate lesion localization. Technological advancements in imaging and localization techniques, such as the development of wireless and radioactive seed localization methods, have improved the precision and safety of breast lesion localization, further fueling market expansion. Additionally, the growing awareness of early detection and the increasing availability of screening programs drive demand. Enhanced research and development activities, along with the introduction of innovative devices and techniques, contribute to market growth by offering more tailored solutions for patients with different medical needs.

Market Restraints:

Despite promising growth prospects, the Breast Lesion Localization Methods Market faces challenges related to the high costs of advanced localization techniques and the potential risks associated with certain methods, such as wire migration or seed displacement. Market growth can be hindered by the availability of alternative imaging and diagnostic solutions, which may be preferred by some healthcare providers due to their non-invasive nature. Additionally, concerns about the accessibility of advanced localization methods in low-resource settings pose challenges for market expansion. Addressing these issues requires ongoing investment in research and development to improve the safety, affordability, and accessibility of breast lesion localization methods.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of non-wire and radioactive seed localization methods, which offer improved patient comfort and outcomes. The development of advanced imaging technologies, such as digital breast tomosynthesis and magnetic resonance imaging (MRI), caters to the growing need for more accurate and less invasive localization options. The expansion of healthcare infrastructure in emerging markets provides new channels for market growth, allowing companies to reach a broader patient population and offer access to cutting-edge localization methods. Strategic partnerships, investments in training programs for healthcare professionals, and the introduction of patient-centered approaches are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Breast Lesion Localization Methods Market globally?
  • Which types and techniques of breast lesion localization are leading the adoption in various healthcare settings?
  • How are technological advancements influencing the competitive landscape of the Breast Lesion Localization Methods Market?
  • Who are the key players in the Breast Lesion Localization Methods Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Breast Lesion Localization Methods Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Breast Lesion Localization Methods Market, including Hologic Inc., Becton, Dickinson and Company, and Leica Biosystems, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced localization solutions and explore new imaging techniques. Collaborations with healthcare providers, research institutions, and technology developers facilitate market access and promote new product adoption. Emphasis on patient education, high-quality products, and comprehensive training programs fosters market growth and enhances brand loyalty in the evolving Breast Lesion Localization Methods Market landscape.

Key Companies Profiled:

  • Merit Medical Systems
  • BD
  • ARGON MEDICAL
  • Hologic, Inc.
  • Endomagnetics Ltd.
  • MatekMedikal
  • Sirius Medical Systems B.V.
  • Izi Medical Products, LLC
  • Molli Surgical Inc
  • Elucent Medical
  • Intramedical Imaging
  • Isoaid
  • Vigeosrl
  • Medax Medical Devices
  • MDL SRL
  • BPB Medica
  • Sterylab S.R.L.
  • Tsunami Medical Srl
  • Laurane(R) Medical LLC
  • Biomedical Srl

Breast Lesion Localization Methods Market Industry Segmentation

By Technology Type

  • Wire Localization
  • Radioguided Localization
  • Magnetic Localization
  • Ultrasound-guided Localization
  • Stereotactic Localization

By End User

  • Hospitals
  • Diagnostic Imaging Centers
  • Specialty Clinics

By Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • Asia Pacific and Oceania
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Breast Lesion Localization Methods Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, (US$ Bn)
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Growth Outlook
    • 2.3.2. Global Healthcare Industry Overview
  • 2.4. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Type Lifecycle Analysis
  • 3.2. Parent Market Analysis
  • 3.3. Disease Epidemiology
  • 3.4. Covid-19 Impact Assessment
  • 3.5. PESTLE Analysis
  • 3.6. Porter Five Force's Analysis
  • 3.7. Regulatory and Technology Landscape

4. Global Breast Lesion Localization Methods Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 4.1. Key Highlights
    • 4.1.1. Market Size and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size Analysis, 2019-2023
    • 4.2.2. Current Market Size Forecast, 2023-2031
  • 4.3. Global Breast Lesion Localization Methods Market Outlook: Technology Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis By Technology Type, 2019-2023
    • 4.3.3. Current Market Size (US$ Bn) Forecast By Technology Type, 2024-2031
      • 4.3.3.1. Wire Localization
      • 4.3.3.2. Radioguided Localization
      • 4.3.3.3. Magnetic Localization
      • 4.3.3.4. Ultrasound-guided Localization
      • 4.3.3.5. Stereotactic Localization
  • 4.4. Market Attractiveness Analysis: Technology Type
  • 4.5. Global Breast Lesion Localization Methods Market Outlook: End-User
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
    • 4.5.3. Current Market Size (US$ Bn) Forecast By End User, 2024-2031
      • 4.5.3.1. Hospitals
      • 4.5.3.2. Diagnostic Imaging Centers
      • 4.5.3.3. Specialty Clinics
  • 4.6. Market Attractiveness Analysis: End User

5. Global Breast Lesion Localization Methods Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 5.3. Current Market Size (US$ Bn) Forecast By Region, 2024-2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa (MEA)
  • 5.4. Market Attractiveness Analysis: Region

6. North America Breast Lesion Localization Methods Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 6.2.1. By Country
    • 6.2.2. By Technology Type
    • 6.2.3. By End User
  • 6.3. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) Forecast By Technology Type, 2024-2031
    • 6.4.1. Wire Localization
    • 6.4.2. Radioguided Localization
    • 6.4.3. Magnetic Localization
    • 6.4.4. Ultrasound-guided Localization
    • 6.4.5. Stereotactic Localization
  • 6.5. Current Market Size (US$ Bn) Forecast By End User, 2024-2031
    • 6.5.1. Hospitals
    • 6.5.2. Diagnostic Imaging Centers
    • 6.5.3. Specialty Clinics
  • 6.6. Market Attractiveness Analysis

7. Europe Breast Lesion Localization Methods Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 7.2.1. By Country
    • 7.2.2. By Technology Type
    • 7.2.3. By End User
  • 7.3. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) Forecast By Technology Type, 2024-2031
    • 7.4.1. Wire Localization
    • 7.4.2. Radioguided Localization
    • 7.4.3. Magnetic Localization
    • 7.4.4. Ultrasound-guided Localization
    • 7.4.5. Stereotactic Localization
  • 7.5. Current Market Size (US$ Bn) Forecast By End User, 2024-2031
    • 7.5.1. Hospitals
    • 7.5.2. Diagnostic Imaging Centers
    • 7.5.3. Specialty Clinics
  • 7.6. Market Attractiveness Analysis

8. East Asia Breast Lesion Localization Methods Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 8.2.1. By Country
    • 8.2.2. By Technology Type
    • 8.2.3. By End User
  • 8.3. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn) Forecast By Technology Type, 2024-2031
    • 8.4.1. Wire Localization
    • 8.4.2. Radioguided Localization
    • 8.4.3. Magnetic Localization
    • 8.4.4. Ultrasound-guided Localization
    • 8.4.5. Stereotactic Localization
  • 8.5. Current Market Size (US$ Bn) Forecast By End User, 2024-2031
    • 8.5.1. Hospitals
    • 8.5.2. Diagnostic Imaging Centers
    • 8.5.3. Specialty Clinics
  • 8.6. Market Attractiveness Analysis

9. South Asia & Oceania Breast Lesion Localization Methods Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 9.2.1. By Country
    • 9.2.2. By Technology Type
    • 9.2.3. By End User
  • 9.3. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn) Forecast By Technology Type, 2024-2031
    • 9.4.1. Wire Localization
    • 9.4.2. Radioguided Localization
    • 9.4.3. Magnetic Localization
    • 9.4.4. Ultrasound-guided Localization
    • 9.4.5. Stereotactic Localization
  • 9.5. Current Market Size (US$ Bn) Forecast By End User, 2024-2031
    • 9.5.1. Hospitals
    • 9.5.2. Diagnostic Imaging Centers
    • 9.5.3. Specialty Clinics
  • 9.6. Market Attractiveness Analysis

10. Latin America Breast Lesion Localization Methods Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 10.2.1. By Country
    • 10.2.2. By Technology Type
    • 10.2.3. By End User
  • 10.3. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn) Forecast By Technology Type, 2024-2031
    • 10.4.1. Wire Localization
    • 10.4.2. Radioguided Localization
    • 10.4.3. Magnetic Localization
    • 10.4.4. Ultrasound-guided Localization
    • 10.4.5. Stereotactic Localization
  • 10.5. Current Market Size (US$ Bn) Forecast By End User, 2024-2031
    • 10.5.1. Hospitals
    • 10.5.2. Diagnostic Imaging Centers
    • 10.5.3. Specialty Clinics
  • 10.6. Market Attractiveness Analysis

11. Middle East & Africa Breast Lesion Localization Methods Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 11.2.1. By Country
    • 11.2.2. By Technology Type
    • 11.2.3. By End User
  • 11.3. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 11.3.1. GCC
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn) Forecast By Technology Type, 2024-2031
    • 11.4.1. Wire Localization
    • 11.4.2. Radioguided Localization
    • 11.4.3. Magnetic Localization
    • 11.4.4. Ultrasound-guided Localization
    • 11.4.5. Stereotactic Localization
  • 11.5. Current Market Size (US$ Bn) Forecast By End User, 2024-2031
    • 11.5.1. Hospitals
    • 11.5.2. Diagnostic Imaging Centers
    • 11.5.3. Specialty Clinics
  • 11.6. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
    • 12.2.3. Apparent Production Capacity
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Merit Medical Systems
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Product Types
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. BD
    • 12.3.3. ARGON MEDICAL
    • 12.3.4. Hologic, Inc.
    • 12.3.5. Endomagnetics Ltd.
    • 12.3.6. MatekMedikal
    • 12.3.7. Sirius Medical Systems B.V.
    • 12.3.8. Izi Medical Products, LLC
    • 12.3.9. Molli Surgical Inc
    • 12.3.10. Elucent Medical
    • 12.3.11. Intramedical Imaging
    • 12.3.12. Isoaid
    • 12.3.13. Vigeosrl
    • 12.3.14. Medax Medical Devices
    • 12.3.15. MDL SRL
    • 12.3.16. BPB Medica
    • 12.3.17. Sterylab S.R.L.
    • 12.3.18. Tsunami Medical Srl
    • 12.3.19. Laurane(R) Medical LLC
    • 12.3.20. Biomedical Srl

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations